Takeda China and Fudan University MBA iLab Join Forces to Cultivate Digital Healthcare Talent

Shanghai, March 30, 2022 /PRNewswire/ -- Recently, with the aim of "cultivating future elites and promoting industry development," the 2022 Fudan University MBA iLab project, initiated by Fudan University MBA and supported by Takeda China, officially kicked off at Takeda China's Shanghai headquarters. This marks the first time Takeda China has collaborated with a prestigious Chinese university. Based on Takeda's value proposition of "putting patients first and being people-centric," and focusing on the Chinese market, this innovative collaboration between universities and enterprises aims to cultivate digital healthcare industry elites and drive the upgrading of the healthcare industry.

Through this collaboration, Takeda China will provide Fudan MBA students with its ongoing specialized business projects, allowing students to purposefully apply the "management theories" they have learned to commercial practices. This aims to cultivate young professionals who possess a truly global perspective while having deep insights into China’s business environment and national conditions. Meanwhile, participating students will collaborate with Takeda China's internal teams to co-create innovative business models or digital healthcare solutions that prioritize "patient needs." This effort will contribute to building a new digital ecosystem in China.

Professor Li Lingfang, Deputy Head of the Department of Applied Economics at Fudan University, Ms. Wang Youliang, Head of Human Resources at Takeda China, Ms. Bai Jie, Head of Business Excellence and Operations at Takeda China, and other guests attended and witnessed the launch ceremony of this project. At the launch meeting, both parties discussed in depth topics such as the demand for industrial transformation and upgrading under the new pattern of the digital economy, the impact of digital innovation on the future landscape of the medical industry, and new models for digital talent cultivation. It was further clarified that the project will focus on the original intention of "patient-centeredness" and explore multiple dimensions such as digital experience, channels, strategy, and operations. Ultimately, it aims to achieve the practical application of the research project in the medical field.

Ms. Youliang Wang, Head of Human Resources at Takeda China, and Ms. Jie Bai, Head of Business Excellence and Operations at Takeda China, jointly stated that as a values-based global biopharmaceutical company that always prioritizes “Patients-Trust-Reputation-Business” in decision-making, Takeda is committed to accelerating R&D innovation and striving to bring more innovative therapies to patients in China, supporting the high-quality development of China's health industry. Takeda China is honored to partner with Fudan University to launch the Fudan MBA iLab project collaboration. Takeda China hopes to add greater value to this program and help cultivate more elite talents with innovative thinking and the ability to lead the future.Takeda ChinaWe also look forward to exchanging ideas with elites from all walks of life, combining innovative thinking with Takeda's technical expertise, starting from the needs of patients, providing new pathways for the high-quality development of China's medical industry, and benefiting more patients.

Professor Li Lingfang stated that, by participating in this Takeda China and Fudan University MBA iLab project, MBA students can gain a deeper understanding of Takeda, a global innovative pharmaceutical enterprise, and its innovative drugs and therapies in the fields of oncology, gastroenterology, rare diseases, and others. They can also draw on Takeda’s excellent experience in exploring new technologies and digital solutions. On the other hand, as an external think tank for Takeda, the MBA students will collaborate with multiple teams within Takeda to participate in the design, research, analysis, and proposal of a series of digital projects initiated by Takeda. They will learn how to design executable healthcare digital solutions from the patient's perspective and provide new solutions and ideas for Takeda China in projects such as digital strategic transformation.

China is becoming a globally influential source of innovation, with the potential to lead in digital healthcare innovation and achieve leapfrog development. It is expected to become a model for digital healthcare innovation in other countries. Takeda China actively embraces the trend of digital transformation in the pharmaceuticals and healthcare industry. Not only is it making active attempts in digital therapeutics and building a digital ecosystem, but it will also take this opportunity to pursue diverse innovative approaches in cultivating digital talent. This aims to achieve two-way empowerment in talent development and industry feedback, ultimately benefiting patients.

FudanIntroduction to the MBA iLab Project

The Fudan MBA iLab project, established in 2005, is one of the classic practice programs highly praised by previous students. It aims to provide cutting-edge topics through corporate collaborations, strengthening students' abilities to think, explore, and solve real business problems. Meanwhile, the Fudan MBA iLab starts from the needs of enterprises, conducting specialized consulting or research work around their development. By positioning MBA students as external think tanks for enterprises, it helps companies analyze practical issues and offer solutions and ideas, thereby contributing to their growth.